Institute of Tropical Medicine, Belgium

itg.be

Total trials

99

Active

19

Phase 3

21

Total enrollment

413,401

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 15 of 15 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Miltefosine3
BE-PEP Bedaquiline1
SDR-PEP Rifampicin1
BE-PEP Rifampicin1
Booster vaccination1
Zabdeno® booster1
Ervebo® booster1
Fusidic Acid1
Sodium Stibogluconate1
Miltefosine + Paromomycin1
Liposomal Amphotericin B1
Pentamidine isethionate1
6EH³R³Z1
6EHRZ1
Mpox vaccination with MVA-BN1

Next readouts

  • 2025-06
  • 2025-12-30
  • 2026-05-20
  • 2026-10
  • 2027-03
  • 2027-03-15
  • 2027-06
  • 2029-03-01

Top conditions

  • Malaria6
  • Malaria in Pregnancy5
  • Cutaneous Leishmaniases5
  • Leprosy4
  • Fever4
  • HIV Infections3
  • Visceral Leishmaniasis3
  • Mpox (Monkeypox)3

Frequently asked questions about Institute of Tropical Medicine, Belgium

How many clinical trials does Institute of Tropical Medicine, Belgium have on ClinicalTrials.gov?
Institute of Tropical Medicine, Belgium is listed as the lead sponsor on 99 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
How many of Institute of Tropical Medicine, Belgium's trials are in Phase 3?
21 of Institute of Tropical Medicine, Belgium's trials are in Phase 3, spread across 15 active drug programs.
What therapeutic areas does Institute of Tropical Medicine, Belgium focus on?
Institute of Tropical Medicine, Belgium's most-studied conditions on ClinicalTrials.gov are Malaria, Malaria in Pregnancy, Cutaneous Leishmaniases, Leprosy, Fever.
When are Institute of Tropical Medicine, Belgium's next clinical trial readouts?
Institute of Tropical Medicine, Belgium has 8 upcoming primary-completion readouts tracked here; the soonest is “Novel Triple-dose Tuberculosis Retreatment Regimen”, expected around 2025-06.